ENHANCE-2 Phase 3 data August 2022 Nasdaq: VRNA | www.veronapharma.com Forward-looking statements This presentation contains "forward‐looking" statements that are based on the beliefs and assumptions and on information currently available to management of Verona Pharma plc (together with its consolidated subsidiaries, the "Company"). All statements other than statements of historical fact contained in this presentation are forward-looking statements. Forward‐looking statements include information concerning ...

Developing innovative therapies for the treatment of respiratory diseases March 2022 Breath of Innovation™ Nasdaq: VRNA | www.veronapharma.com Forward-looking statements This presentation contains "forward‐looking" statements that are based on the beliefs and assumptions and on information currently available to management of Verona Pharma plc (together with its consolidated subsidiaries, the "Company"). All statements other than statements of historical fact contained in this presentation are forward-looki ...

Verona Pharma plc (NASDAQ:VRNA) Q1 2022 Earnings Conference Call May 3, 2022 9:00 AM ET Company Representatives Dr. David Zaccardelli - Chief Executive Officer Mark Hahn - Chief Financial Officer Dr. Kathy Rickard - Chief Medical Officer Chris Martin - Senior Vice President of Commercial Conference Call Participants Suji Jeong - Jefferies Andreas Argyrides - Wedbush Securities Boobalan Pachaiyappan - H.C. Wainwright Edward Nash - Canaccord Genuity Joon Lee - Truist Securities Operator Welcome to Verona Phar ...

Developing innovative therapies for the treatment of respiratory diseases March 2022 Breath of Innovation™ Nasdaq: VRNA | www.veronapharma.com Forward-looking statements This presentation contains "forward‐looking" statements that are based on the beliefs and assumptions and on information currently available to management of Verona Pharma plc (together with its consolidated subsidiaries, the "Company"). All statements other than statements of historical fact contained in this presentation are forward-looki ...

Call Start: 09:00 January 1, 0000 9:33 AM ET Verona Pharma plc (NASDAQ:VRNA) Q4 2021 Earnings Conference Call March 3, 2022 09:00 ET Company Participants David Zaccardelli - President & Chief Executive Officer Mark Hahn - Chief Financial Officer Chris Martin - Senior Vice President of Commercial Kathleen Rickard - Chief Medical Officer Conference Call Participants Andreas Argyrides - Wedbush Securities Suji Jeong - Jefferies Tom Shrader - BTIG Operator Welcome to Verona Pharma's Fourth Quarter and Year End ...

Verona Pharma plc (NASDAQ:VRNA) Q3 2021 Earnings Conference Call November 9, 2021 9:00 AM ET Company Participants David Zaccardelli - President and Chief Executive Officer Mark Hahn - Chief Financial Officer Kathy Rickard - Chief Medical Officer Conference Call Participants Andreas Argyrides - Wedbush Securities Boobalan Pachaiyappan - H.C. Wainwright Tom Shrader - BTIG Operator Welcome to Verona Pharma's Third Quarter 2021 Financial Results and Operating Highlights Conference Call. At this time, all partic ...

Nasdaq: VRNA | www.veronapharma.com Developing innovative therapies for the treatment of respiratory diseases August 2021 Breath of Innovation™ Forward-looking statements This presentation contains "forward‐looking" statements that are based on the beliefs and assumptions and on information currently available to management of Verona Pharma plc (together with its consolidated subsidiaries, the "Company"). All statements other than statements of historical fact contained in this presentation are forward-look ...

Verona Pharma plc (NASDAQ:VRNA) Q2 2021 Earnings Conference Call August 5, 2021 8:30 AM ET Company Participants David Zaccardelli - President and CEO Mark Hahn - CFO Kathy Rickard - CMO Chris Martin - VP, Commercial Conference Call Participants Suji Jeong - Jefferies Sung Hong - BTIG Operator Welcome to Verona Pharma's Second Quarter 2021 Financial Results and Operating Highlights Conference Call. At this time, all participants are in a listen-only mode. Earlier this morning, Verona Pharma issued a press re ...

Verona Pharma plc (NASDAQ:VRNA) Q1 2021 Earnings Conference Call April 29, 2021 9:00 AM ET Company Participants David Zaccardelli - President and CEO Mark W. Hahn - CFO Kathleen Rickard - CMO Christopher Martin - VP, Commercial Conference Call Participants Suji Jeong - Jefferies Liana Moussatos - Wedbush Securities Edward Nash - Canaccord Genuity Miguel Coelho - Truist Securities Operator Welcome to Verona Pharma's First Quarter 2021 Financial Results and Operating Highlights Conference Call. At this time, ...

Verona Pharma plc (NASDAQ:VRNA) Q4 2020 Earnings Conference Call February 25, 2020 9:00 AM ET Company Participants David Zaccardelli - CEO Mark Hahn - CFO Kathy Rickard - CMO Chris Martin - VP, Commercial Conference Call Participants Tom Shrader - BTIG Suji Jeong - Jefferies Andreas Argyrides - Wedbush Securities Joon Lee - Truist Securities Operator Welcome to Verona Pharma's Fourth Quarter and Year End 2020 Financial Results and Operating Highlights Conference Call. At this time, all participants are in a ...